This month theme issue editor, Trahern Jones, a fourth-year student at Mayo Medical School in Rochester, Minnesota, spoke with Dr. Edward Laskowski about the use of performance-enhancing drugs and substances among athletes today.
In the September 2014 issue on physicians as agents of social change, Dr. Audiey Kao, editor-in-chief of Virtual Mentor interviewed Dr. Rajiv Shah, administrator of the United States Agency for International Development or USAID.
When a seriously ill mature minor and his parent disagree about his receiving an experimental intervention, who should decide what treatment he will receive?
Courts considering teenagers' refusal of life-saving treatments often consider their maturity, the beliefs underlying the refusal, their parents' wishes, and the chances that treatment would cure them.
Some treatments of childhood cancer can cause infertility in adulthood. What should be the roles of physicians in helping parents decide whether, when, and what their child is told about this risk?
AMA J Ethics. 2017;19(5):426-435. doi:
10.1001/journalofethics.2017.19.5.ecas2-1705.
Is it ethical to create and advertise, either publicly or during office visits, package deals that offer patients an incentive to have procedures they are not already seeking and might not have considered?
Within the patient-physician relationship, the request for neuroenhancement becomes a chief concern, and the physician has a duty to take a history and perform a physical exam to determine whether the patient’s current level of function represents significant change.